Skip to main content

Table 2 Financial implications for ‘A Country’ in preventing hospitalisations due to adverse drug reactions

From: Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence

Annual number of hospital admissions

500,000

No. of admissions at a 4 -6% ADR incidence level

20,000 - 30,000

At an average length of stay of 5 days

100,000 – 150,000

At an average cost of £300/day

£30 m - £45 m

Potential savings (based on 50%-70% preventability)

£15 m - £31.5 m

  1. (NB Average length of stay and daily costs will be country specific).